DiNAQOR AG, a global gene therapy platform company, today announced a research collaboration and exclusive license agreement with UCL to develop novel gene ther [...]
A FVIII gene therapy treatment, developed by world leading gene therapy expert, Professor Amit Nathwani at UCL has shown positive results in treating patients w [...]
BioMarin today announced it has submitted a marketing application to the European Medicines Agency (EMA), for the investigational gene therapy, valoctocogene ro [...]
UCLB, part of UCL Innovation & Enterprise, launches its search for early-stage social ventures to benefit from Proof of Concept funding. The initiative will [...]
The launch of Portico Ventures sees the introduction of two new models for intellectual property (IP) commercialisation to support UCL staff who have created no [...]
UCLB has concluded an exclusive agreement to license a collection of pre-clinical small molecule compounds for the treatment of alpha-1-antitrypsin deficiency w [...]
Echopoint Medical Ltd, a spinout company from UCL, has raised £2.8m to develop optical sensing technology to help heart disease patients in a grey zone where th [...]
Congratulations to medical device spinout Endomag who has been named in The Sunday Times Tech Track 100 list. The list ranks Britain’s 100 private tech (TMT) co [...]
We are delighted to announce that four UCLB spinout companies have been named finalists for the 2019 European Lifestars Awards. Ixico has been shortlisted for t [...]
Achilles Therapeutics, a biopharmaceutical company launched in 2016, based on work led by Professor Charles Swanton of UCL and the Francis Crick Institute, has [...]
